Product Information: Bortezomib
Bortezomib
| Cat. No. | HXO-00482 |
|---|---|
| CAS. No. | 179324-69-7 |
| Category | API Standards |
| Stock Status | Instock |
| Molecular Formula | C19H25BN4O4 |
| Molecular Weight | 384.24 mol/g |
| Application | "Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells." |
Get Quick Quote
Global Delivery
We deliver across the globe.
Quality
We follow strict QC for all synthesis.
Instant Support
We offer support 24x7.